IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GUAZZI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.151
AS - Asia 22.021
NA - Nord America 20.558
SA - Sud America 2.506
AF - Africa 431
OC - Oceania 142
Continente sconosciuto - Info sul continente non disponibili 9
Totale 67.818
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.932
GB - Regno Unito 7.299
CN - Cina 6.800
SG - Singapore 6.728
IT - Italia 3.448
RU - Federazione Russa 2.357
DE - Germania 2.160
HK - Hong Kong 2.017
BR - Brasile 1.788
VN - Vietnam 1.451
SE - Svezia 1.394
FR - Francia 1.257
BD - Bangladesh 1.116
IN - India 1.040
IE - Irlanda 792
NL - Olanda 769
KR - Corea 678
FI - Finlandia 654
TR - Turchia 635
UA - Ucraina 597
JP - Giappone 465
CA - Canada 371
ID - Indonesia 362
EU - Europa 277
CO - Colombia 239
ES - Italia 200
AR - Argentina 187
PL - Polonia 167
BE - Belgio 158
DK - Danimarca 133
MX - Messico 132
AT - Austria 127
GR - Grecia 122
AU - Australia 119
CI - Costa d'Avorio 111
IQ - Iraq 94
CL - Cile 91
PT - Portogallo 91
CH - Svizzera 84
TW - Taiwan 84
NO - Norvegia 71
ZA - Sudafrica 59
RO - Romania 57
PH - Filippine 52
PK - Pakistan 52
VE - Venezuela 50
TH - Thailandia 48
SA - Arabia Saudita 45
MY - Malesia 44
EC - Ecuador 42
IL - Israele 42
PE - Perù 41
TN - Tunisia 38
EG - Egitto 37
MA - Marocco 35
CZ - Repubblica Ceca 34
UZ - Uzbekistan 34
PY - Paraguay 33
KE - Kenya 31
AE - Emirati Arabi Uniti 30
JO - Giordania 29
CR - Costa Rica 27
RS - Serbia 26
ET - Etiopia 25
NZ - Nuova Zelanda 22
DZ - Algeria 21
JM - Giamaica 20
AZ - Azerbaigian 19
UY - Uruguay 19
IR - Iran 18
KZ - Kazakistan 18
LT - Lituania 17
HR - Croazia 16
LU - Lussemburgo 15
BG - Bulgaria 14
HU - Ungheria 13
LB - Libano 13
NG - Nigeria 13
NP - Nepal 13
KG - Kirghizistan 12
BA - Bosnia-Erzegovina 11
GT - Guatemala 11
LV - Lettonia 11
TT - Trinidad e Tobago 11
BO - Bolivia 10
HN - Honduras 10
MU - Mauritius 10
PA - Panama 10
QA - Qatar 10
SN - Senegal 10
EE - Estonia 9
OM - Oman 9
DO - Repubblica Dominicana 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
BY - Bielorussia 7
GE - Georgia 7
KH - Cambogia 7
MD - Moldavia 7
Totale 67.952
Salva come PNG Salva come JPEG
Città #
Southend 6.534
Singapore 3.712
Hong Kong 1.893
Ashburn 1.652
San Jose 1.372
Chandler 1.219
Beijing 1.197
Seattle 1.108
Milan 1.054
Princeton 979
Council Bluffs 863
Dublin 784
Wilmington 714
Dallas 668
Ann Arbor 662
Los Angeles 569
Bengaluru 516
Frankfurt am Main 516
Santa Clara 502
Hefei 499
Lauterbourg 485
Ho Chi Minh City 440
New York 439
Jacksonville 428
Nanjing 395
Fairfield 385
Redmond 382
Boardman 378
Guangzhou 358
Moscow 357
Hanoi 353
Buffalo 318
Des Moines 318
Mountain View 296
Dearborn 273
Houston 268
Shanghai 243
Woodbridge 240
Helsinki 234
Sakarya 188
The Dalles 187
Rome 176
Columbus 175
Cangzhou 172
Hangzhou 171
Tianjin 168
Bogotá 161
Tokyo 161
São Paulo 149
Redwood City 147
Toronto 142
Jakarta 139
Serra 138
Andover 134
Munich 134
Shenyang 132
Shenzhen 130
Jinan 126
Seoul 126
Changsha 121
Berlin 118
Somerville 118
Chicago 114
Nanchang 114
Abidjan 110
Warsaw 108
Cambridge 106
Nuremberg 92
Athens 89
Phoenix 84
Atlanta 82
Naples 78
Amsterdam 76
Eitensheim 75
Hebei 75
Brussels 74
San Diego 70
Sunnyvale 68
Turin 68
Rio de Janeiro 67
Jiaxing 63
Vienna 63
Zhengzhou 60
Haiphong 59
Washington 59
Santiago 58
Da Nang 57
Istanbul 57
London 55
Bologna 54
Kunming 53
Montreal 53
Fuzhou 52
Hamburg 51
Taipei 49
San Francisco 46
Madrid 45
Verona 44
Dong Ket 41
Brooklyn 40
Totale 39.625
Salva come PNG Salva come JPEG
Nome #
2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure : the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) : developed with the special contribution of the Heart Failure Association (HFA) of the ESC 1.443
EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations 1.208
Exercise intolerance in chronic heart failure : mechanisms and therapies. Part I 1.032
Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction 544
Predictors of abnormal heart rate recovery in patients with heart failure reduced and preserved ejection fraction 458
Cardiovascular death risk in recovered mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test 390
Left Atrial Strain in Acute Heart Failure: Clinical and Prognostic Insights 382
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 337
Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease : a pilot study 296
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 287
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 287
Effects of Physical Exercise on Endothelial Function and DNA Methylation 285
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 283
A case for assessment of oscillatory breathing during cardiopulmonary exercise test in risk stratification of elderly patients with chronic heart failure 282
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry 278
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 274
Respiratory exchange ratio overshoot during exercise recovery: a promising prognostic marker in HFrEF 260
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats 255
Abdominal obesity phenotype is associated with COVID-19 chest X-ray severity score better than BMI-based obesity 248
Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium 239
Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients 235
Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure : an index of right ventricular contractile function and prognosis 235
Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients 232
Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of HIF-1α signaling 227
Dysfunctional EAT thickness may promote maladaptive heart remodeling in CVD patients through the ST2-IL33 system, directly related to EPAC protein expression 226
Effects of treatment strategy on endothelial function 222
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients 219
Tessuto adiposo epicardico: dagli aspetti biomolecolari alla pratica clinica = Epicardial adipose tissue: from biomolecular aspects to clinical practice 217
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 217
Nebivololo efficacy on pressure control and endothelial dysfunction in hypertensive post-menopausal women 215
H-1- and P-31-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes 215
Arrhythmogenic Mitral Valve Prolapse and Sudden Cardiac Death: an Update and Current Perspectives 214
Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation 213
Oxygen transport in blood at high altitude : role of the hemoglobin-oxygen affinity and impact of the phenomena related to hemoglobin allosterism and red cell function 210
Exercise ventilation inefficiency and cardiovascular mortality in heart failure : the critical independent prognostic value of the arterial CO2 partial pressure 210
Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients : A pilot study 210
The prognostic power of the endothelial flow-mediated dilatation in uncomplicated acute myocardial infarction with preserved systolic function 209
Impact of right ventricular dysfunction on the outcome of heart failure patients undergoing surgical ventricular reconstruction 202
The chronic heart failure evolutions: Different fates and routes 200
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure : data from the MECKI Score Research Group 197
Calcium channel blockade in heart failure 196
Prognostic role of atrial fibrillation in patients affected by chronic heart failure : data from the MECKI score research group 196
Effects of orthostatic stress on forearm endothelial function in normal subjects and in patients with hypertension, diabetes, or both diseases 195
Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors 195
Exercise Oscillatory Breathing And Increased Ventilation To CO2 Production Slope In Heart Failure: an Unfavorable Combination With High Prognostic Value 192
Sexual dysfunction in pre-menopausal diabetic women : clinical, metabolic, psychological, cardiovascular, and neurophysiologic correlates 191
Relative peak exercise oxygen pulse is related to sudden cardiac death, cardiovascular and all-cause mortality in middle-aged men 191
Right Ventricular Contractile Reserve and Pulmonary Circulation Uncoupling During Exercise Challenge in Heart Failure: Pathophysiology and Clinical Phenotypes 190
Heart failure patients with improved ejection fraction: insights from the MECKI Score database 189
PDE5-Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry and Clinical Status In Patients With Stable Systolic Heart Failure: Results of a 1-Year Prospective, Randomized, Placebo-Controlled Study 189
Impaired brachial artery endothelial flow-mediated dilation and orthostatic stress in hemodialysis patients 188
Prognostic value of indeterminable anaerobic threshold in heart failure 186
Prognostic role of beta-blocker selectivity and dosage regimens in heart failure patients : Insights from the MECKI score database 186
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 186
Recovery of exercise capacity after COVID-19 pneumonia: Key role of right ventricular-pulmonary circulation unit: The role of pulmonary vasculature in exercise after COVID-19 pneumonia 186
Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes : different results with cardioversion 184
Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention 184
Recoupling of right and left ventricle pump function after surgical ventricle restoration : a cardiac magnetic resonance study 184
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure : Application of Metabolic Exercise Cardiac Kidney Indexes Score 184
Vascular involvement in idiopathic pulmonary fibrosis 183
The Additional Value of Three-Dimensional Transesophageal Echocardiography in the Diagnosis of Unusual Complication of Bioprosthetic Mitral Valve 183
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 183
Pulmonary embolism in patients with COVID‑19: characteristics and outcomes in the Cardio‑COVID Italy multicenter study 183
RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes 182
Evolving changes in lung interstitial fluid content after acute myocardial infarction : mechanisms and pathophysiological correlates 181
Functional evaluation of patients with chronic pulmonary hypertension 181
6 minute walk test and cardiopulmonary exercise testing in chronic heart failure : a comparative analysis on clinical and prognostic insights 180
A geometric index to differentiate abnormal from normal septal wall motion on cardiac MRI 180
Reversibility of cardiopulmonary impairment after laparoscopic repair of large hiatal hernia 180
Acute blood pressure reduction in the presence of hypertensive cardiac hypertrophy: any interference with coronary circulation? 179
Adenosine activates cardiac sympathetic afferent fibers and potentiates the excitation induced by coronary occlusion 178
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 178
Chronic sildenafil therapy improves quality of life, exercise oxygen uptake and ventilation efficiency in stable heart failure patients 177
Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation 176
Impact of Right Ventricular‐Pulmonary Circulation Coupling on Mortality in SARS‐CoV‐2 Infection 176
The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure 174
Pulmonary hypertension due to left heart disease 174
Powerlful prognostic and clinical insights combining TAPSE and PASP in heart failure : correlation and additive value with cardiopulmonary exercise response 172
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 172
Chronic sildenafil therapy improves quality of life, exercise oxygen uptake and ventilation efficiency in stable heart failure patients 171
Ultrafiltration in moderate heart failure. Exercise oxygen uptake as a predictor of the clinical benefits 171
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 171
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management 170
Six months of Sildenafil therapy improves heart rate recovery in patients with heart failure 170
The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope 169
Exercise ventilation inefficiency and cardiovascular mortality in heart failure: The critical independent prognostic value of the arterial CO2 partial pressure 168
Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients 168
The relationship between tricuspid annular systolic excursion and pulmonary arterial systolic pressure in heart failure : an indicator of cardiac lengh versus force relationship that discloses disease severity and prognosis 168
Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle 168
Letter by Bandera et al regarding article, "Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation" 167
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure : A validation study 166
A long term follow-up study of patients with mild to moderate group 2 pulmonary hypertension treated with Pde5-inhibition: a comparison between heart failure with reduced and preserved ejection fraction 165
Non-invasive measurement of stroke volume during exercise in heart failure patients 164
Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing 163
[Relation between the therapeutic efficacy of nifedipine in exercise-induced, mixed and spontaneous angina and acute coronary vasomotor effects evaluated by quantitative angiography] 163
Severity does not impact on exercise capacity in COVID-19 survivors 163
Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure 162
Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy 161
Surgical ventricular restoration : is there any difference in outcome between anterior and posterior remodeling? 161
Sex profile and risk assessment with cardiopulmonary exercise testing in heart failure: propensity score matching for sex selection bias 161
Totale 24.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 0 0 229
2021/20224.566 415 254 290 209 411 293 415 208 364 460 360 887
2022/20235.450 724 299 468 566 842 1.097 127 301 556 71 243 156
2023/20244.284 144 324 169 429 969 267 196 238 110 270 579 589
2024/202510.655 468 1.185 258 903 704 420 365 1.280 609 967 1.338 2.158
2025/202623.469 1.937 1.475 2.335 1.850 2.137 1.728 2.461 1.556 2.931 1.845 2.581 633
Totale 71.880